Greenwich Lifesciences Stock Analysis

Greenwich Stock Analysis Notes

About 52.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.27. Greenwich Lifesciences had not issued any dividends in recent years. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Greenwich Lifesciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. To learn more about Greenwich Lifesciences call Snehal Patel at 832-819-3232 or check out https://greenwichlifesciences.com.

Greenwich Lifesciences Investment Alerts

Greenwich Lifesciences Upcoming and Recent Events

Greenwich Largest EPS Surprises

View All Earnings Estimates

Greenwich Lifesciences Environmental, Social, and Governance (ESG) Scores

Greenwich Stock Institutional Investors

Note, although Greenwich Lifesciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Greenwich Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 157.21 M.

Greenwich Profitablity

Management Efficiency

Greenwich Lifesciences has return on total asset (ROA) of (2.5355) % which means that it has lost $2.5355 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.1527) %, meaning that it created substantial loss on money invested by shareholders. Greenwich Lifesciences' management efficiency ratios could be used to measure how well Greenwich Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -4.05. The Greenwich Lifesciences' current Return On Capital Employed is estimated to increase to -6. As of now, Greenwich Lifesciences' Net Tangible Assets are increasing as compared to previous years. The Greenwich Lifesciences' current Other Assets is estimated to increase to 1,868, while Total Assets are projected to decrease to under 3.9 M.

Technical Drivers

As of the 22nd of July, Greenwich Lifesciences retains the Downside Deviation of 2.87, risk adjusted performance of 0.1371, and Market Risk Adjusted Performance of 0.3603. Greenwich Lifesciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Greenwich Lifesciences Price Movement Analysis

Greenwich Lifesciences Insider Trading Activities

Greenwich Lifesciences Outstanding Bonds

Greenwich Lifesciences Predictive Daily Indicators

Greenwich Lifesciences Corporate Filings

Greenwich Lifesciences Forecast Models

Greenwich Lifesciences' time-series forecasting models are one of many Greenwich Lifesciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Greenwich Lifesciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Greenwich Lifesciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Greenwich shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Greenwich Lifesciences. By using and applying Greenwich Stock analysis, traders can create a robust methodology for identifying Greenwich entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Greenwich analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Greenwich analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Greenwich Lifesciences stock analysis indicators help investors evaluate how Greenwich Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Greenwich Lifesciences shares will generate the highest return on investment. By understating and applying Greenwich Lifesciences stock analysis, traders can identify Greenwich Lifesciences position entry and exit signals to maximize returns.

When running Greenwich Lifesciences' price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.